Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2026-03-09 @ 7:21 AM
Study NCT ID:
NCT06651151
Status:
RECRUITING
Last Update Posted:
2024-10-26
First Post:
2024-10-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
Sponsor:
Organization: